Evidence in the diagnosis and treatment of postpartum depression: a narrative review

• Autores: Fuentes-Ureña, Valeria, T. Herrera, Tania, Orobio MD, Allissan, Manzano, Miguel, Blanco, Isabel, Hinestroza-Newball, Anthonier
• Formato: artículo
• Fecha de Publicación: 2024
• Institución: Sociedad Peruana de Obstetricia y Ginecología
• Repositorio: Revista Peruana de Ginecología y Obstetricia
• Lenguaje: español; inglés
• OAI Identifier: oai:ginecologiayobstetricia.pe:article/2592
• Enlace del recurso: https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2592
• Nivel de acceso: acceso abierto
• Materia: Pregnancy; Depression; postpartum; Drug therapy; Embarazo; Depresión posparto; Farmacoterapia

Introduction: Postpartum depression is one of the most common medicalcomplications associated with adverse short- and long-term perinatal outcome inthe mother, infant, and family. Objective: To describe various diagnostic methodsand therapies used for the management of postpartum depression and toanalyze the recommendations generated by different scientific groups (maternalfetalmedicine, American College of Obstetrics and Gynecology, NICE guidelines,psychiatry, pediatrics). Methodology: Different search strategies were used in thedatabases Medline (via Pubmed), Scopus, Web of Science, Embase, Cochrane, OVIDPsycho, from January 01, 2020 to February 01, 2023, using the keywords "postpartumdepression", "antidepressants", "cognitive behavioral therapy", "interpersonaltherapy", "mindfulness", controlled vocabulary. Two investigators independentlyreviewed study titles and abstracts. Results: About 14% of pregnant women developpostpartum depression. The most relevant risk factors are a history of anxiety,depression, history of psychiatric treatment, history of physical abuse, postpartummedical complications. Conclusions: One in seven patients (14%) develop perinataldepression. Tools such as the Edinburgh Scale should be applied to all pregnantwomen at their first prenatal check-up appointment, during the third trimester andin the postpartum period. There are several safe therapies that have demonstratedsymptom reduction and decreased levels of relapse, with few side effects.